Roman Kasianov - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Roman Kasianov's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Roman Kasianov
Verified
Director and Head of Content, BiopharmaTrend
Kyiv City
health & well being., SAP Related Discussions, Scientific Research, Technology And Innovation , Personal Development , Motivation
Content
By Roman Kasianov| BiopharmaTrend Verified Elix and PRISM BioLab have announced a partnership aimed at advancing drug discovery for protein-protein interaction (PPI) targets—an area long considered difficult to address with small molecules. The collaboration brings together Elix’s AI-driven compound design capabilities and PRISM BioLab’s small molecule scaffolds that mimic structural motifs found in intracellular protein interfaces.
By Roman Kasianov| Where Tech Meets Bio@ Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies. We’ve also just released a new report outlining a framework for what defines modern AI-driven drug discovery, for 2025 and beyond. If this newsletter is in your inbox, it’s because you subscribed or someone thought you might enjoy it.
By Roman Kasianov| BiopharmaTrend Verified Elix and PRISM BioLab have announced a partnership aimed at advancing drug discovery for protein-protein interaction (PPI) targets—an area long considered difficult to address with small molecules. The collaboration brings together Elix’s AI-driven compound design capabilities and PRISM BioLab’s small molecule scaffolds that mimic structural motifs found in intracellular protein interfaces.
Company Info
BiopharmaTrend
BioPharmaTrend.com is a London-based digital platform established in 2016. It focuses on providing news, trends, and analysis for the biotechnology, pharmaceutical, and healthcare sectors. The platform serves professionals looking for insights into technological advancements, investment trends, and industry events. The company offers a range of services, including industry insights through market research and technology scouting, as well as content streams featuring articles, interviews, and case studies. It also provides educational resources that simplify complex topics for decision-makers in the life sciences field. Additionally, BioPharmaTrend.com collaborates with an advisory board to ensure the relevance and accuracy of its content. Targeting investors, business leaders, consultants, and government professionals, BioPharmaTrend.com aims to deliver reliable insights that support informed decision-making in the biopharma and healthcare industries.
Founded: 2016